Table of Contents How Retatrutide and Sermorelin Work in the Body Potential Interactions Between Retatrutide and Sermorelin What the Current Evidence and Guidelines Say Risks and Safety Considerations for Combined Use When to Seek Advice from a UK Prescriber or Specialist Alternatives and Next Steps for Weight or Hormone Management Scientific References Frequently Asked Questions How Retatrutide and Sermorelin Work in the Body Retatrutide activates GLP-1, GIP, and glucagon receptors to reduce appetite and body weight, whilst sermorelin stimulates pituitary growth hormone release via the GHRH pathway
MDA, SOD, and GSH-PX The concentration of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-PX) in the blood were determined using MDA, SOD, and GSH-PX assay kits (Beyotime, China), respectively, following the manufacturers instructions
You could experience some serious side effects, such as worsening diabetic retinopathy, even after Ozempic has been fully cleared from your system
It is also important to be aware of possible side effects, which are usually mild and commonly include nausea, bloating, constipation, or diarrhea
MHRA Guidance and Reporting Suspected Side Effects Adverse events during a retatrutide clinical trial must be reported to the trial team and sponsor under UK Clinical Trials Regulations
and may also be good for circulation disorders